Ataxia د.رشاد عبدالغني

download Ataxia د.رشاد عبدالغني

of 21

Transcript of Ataxia د.رشاد عبدالغني

  • 8/3/2019 Ataxia .

    1/21

    AtaxiaThe basic anatomy of cerebellum (CB):

    The CB occupies the posterior cranial fossa and covered by thetentorium cerebelli. It consists of 2 hemispheres joined by a medianvermis. The cerebellar cortex is divided into 3 lobes by 2 deeptransverse fissures

  • 8/3/2019 Ataxia .

    2/21

    Functional divisions of the CB

    Vestibulocerebellum

    (archicerebellum)

    Spinocerebellum

    (paleocerebellum)

    Cerebro-

    cerebellum

    (neo-

    cerebellum)

  • 8/3/2019 Ataxia .

    3/21

    Connections of the cerebellum

    Aference copy

    Afference copy

    Corrective signals

  • 8/3/2019 Ataxia .

    4/21

    CEREBELLAR DYSFUNCTION

    Cerebellar lesion Signs

    Posterior(Flocculo-nodular lobe;Archicerebellum)Eye movement disorders: Nystagmus;Vestibulo-ocular reflex (VOR)Postural and gait dysfunction

    Midline(Vermis; paleocerebellum) Truncal & gait ataxia

    Hemisphere(Neocerebellum)Limb ataxia: Dysmetria, Dysdiadochokinesis,"intention" tremorDysarthriaHypotonia

  • 8/3/2019 Ataxia .

    5/21

    AtaxiasThe word ataxia simply means lack of co-ordination. So ataxias are disorders in which the

    nervous system (including the cerebellum) is

    affected, causing unsteadiness and lack of co-ordination. Several brain areas, including the

    cerebellum and the spinocerebellar tracts,

    thalamus, pons, and cerebral cortex control these

    functions. Injuries in one or more of these areas

    or in the spinal cord may lead to some form of

    ataxia.

  • 8/3/2019 Ataxia .

    6/21

    Ataxia is

    either

    sensoryor motor.

    Type Sensory ataxia Motor ataxia

    Most common

    cause

    Tabes dorsalis Cerebellar

    disease

    Gait high steppage

    (stamping)

    Staggering

    Romberg signs Positive Negative

    Effect of vision Corrected by

    vision

    Not affected by

    vision

    Deep sensations Impaired or lost Normal

    Tremors Absent Kinetic tremorpresent

    Nystagmus Absent Present

    Speech Normal Scanning orstaccato

  • 8/3/2019 Ataxia .

    7/21

    Causes & classification of ataxias

    Some types of ataxia are inherited and some are not

    Developmental

    Chiari malfaormation

    Dandy walker syndromeCerebellar aplasia

    Basilar impression

  • 8/3/2019 Ataxia .

    8/21

    Hereditary

    Autosomal dominant:Spinocerebellar ataxias (SCAs)

    Dentatorubral-pallidoluysian atrophy (DRPLA)

    Episodic ataxia type 1 (EA-1)Episodic ataxia type 2 (EA-2) Hereditary motor

    and sensory neuropathy type I [HMSN1 or

    (CMT1)]

  • 8/3/2019 Ataxia .

    9/21

    Autosomal recessive:

    Friedreichs ataxia

    Ataxia telangiectasia

    Ataxia with ocular motor apraxia

    Ataxia with Isolated Vitamin E deficiency

  • 8/3/2019 Ataxia .

    10/21

    Disease Name PopulationFrequencyOnset(Range inYears)

    Duration(Years) Distinguishing Features

    Friedreich ataxia(FRDA) 1-2/50,0001st - 2nddecade(4-40) 10 - 30

    Hyporeflexia,Babinski responses,sensory loss,cardiomyopathy

    Ataxia-telangiectasia(A-T)1/40,000to1/100,000 1st decade 10 - 20

    Telangiectasia,immune deficiency, cancer, chromosomalinstability, increased alpha-fetoprotein

    Ataxia with vitamin Edeficiency(AVED) Rare2-52 years,usually

  • 8/3/2019 Ataxia .

    11/21

    Ataxia with identified biochemical defect

    AbetalipoproteinemiaCerebrotedinous Xanthomatosis

    Nieman pick disease

    Refsum diseseWilson disese

    Leukodystrophies

    Ceroid lipofuscinosisHexosaminidase deficiency

  • 8/3/2019 Ataxia .

    12/21

    X-linked ataxias

    Fragile x-tremor ataxia

    Ataxia with spasticity

    with mental retardation

    with deafness

    Mitochondrial

    NARP (neuropathy, ataxia, and retinitis pigmentosa)

    MELAS (mitochondrial encephalomyopathy, lactic acidosis

    with stroke-like episodes)

    Myoclonus epilepsy with ragged red fibres (MERRF)

    Co-Q10 deficiency

  • 8/3/2019 Ataxia .

    13/21

    Non-inherited ataxiasAutoimmuneMiller-Fisher

    Multiple sclerosis

    Paraneoplastic

    Infections:Viral encephalitis,

    Bacterial

    Fungal

    Parasites

    Creutzfeldt-Jakob

    Vascular

    Infarction

    Haemorrhage

    Vascular

    malformation

    Vasculitidis

    Systemic

    Amyloid

    EndocrineHypoparathyroidism Hypothyroidism

    GI disorders

    Celiac disease; Sprue

    Vitamin E malabsorption

    Whipples diseaseMultiple system atrophy

    Mass lesion

    Abscess

    NeoplasmSarcoid

    Toxins & Drugs

    Anticonvulsants

    Chemotherapeutic

    agentsHeavy metals

    Alcohol

    Trauma

    Vestibular

    (labrynthytis)

    http://www.neuro.wustl.edu/neuromuscular/ataxia/recatax.htmlhttp://www.neuro.wustl.edu/neuromuscular/ataxia/recatax.html
  • 8/3/2019 Ataxia .

    14/21

    Friedreich ataxia (FA, FRDA)

    Friedreich ataxia (FA, FRDA) is an autosomal

    recessive ataxia resulting from a mutation of a gene

    locus on chromosome 9.

    It accounts for at least 50% of cases of hereditary

    ataxias in most large series. Cardinal features include

    progressive limb and gait ataxia, dysarthria, loss of

    joint position and vibration senses, absent tendonreflexes in the legs, and extensor plantar responses.

  • 8/3/2019 Ataxia .

    15/21

    PathophysiologyFRDA is a result of a mutation of a gene locus on

    chromosome 9. This mutation is characterized by

    an excessive number of repeats of the GAA

    (guanine adenine adenine) trinucleotide DNA

    sequence. This mutation result in a deficiency of

    frataxin, which causes defects of mitochondrial

    oxidative phosphorylation with accumulation offree radicals in tissues.

  • 8/3/2019 Ataxia .

    16/21

    The major pathophysiologic finding in FA is a

    "dying back phenomena" of axons, and a

    secondary gliosis. The primary sites of thesechanges are the spinal cord and spinal roots.

    Myocardial muscle fibers also show degeneration

    and are replaced by macrophages and fibroblasts.

  • 8/3/2019 Ataxia .

    17/21

    Epidemiology

    FA is a relatively common disorder. It is the

    most common autosomal recessive ataxia,

    accounting for approximately 50% of all cases of

    hereditary ataxia. Estimates of incidence range

    anywhere from 1 in 22,000 to 2 in 100,000.

    Age: The onset of FA is early; it typicallypresents in children aged 8-15 years and almost

    always presents before age 20 years.

    Cli i l f

  • 8/3/2019 Ataxia .

    18/21

    Clinical features:

    Onset of FA is early, with gait ataxia being theusual presenting symptom. As the disease

    progresses, ataxia affects the trunk, legs, and

    arms. Patients with advanced FA may have

    profound distal weakness of the legs. Eventually,

    the patient is unable to walk because of the

    progressive weakness and ataxia.

  • 8/3/2019 Ataxia .

    19/21

    The cardinal features of FA are as follows:

    Progressive limb and gait ataxia develops beforethe age of 30 years.

    Lower extremity tendon reflexes are absent.

    Evidence of axonal sensory neuropathy is noted.Extensor plantar responses (90%)

    Foot deformity, scoliosis, diabetes mellitus, and

    cardiac involvement are other commoncharacteristics.

  • 8/3/2019 Ataxia .

    20/21

    Investigations:

    Vitamin E levels were normal and no

    acanthocytes were identified. Magnetic resonance

    scan shows cervical cord atrophy with preserved

    cerebellar anatomy. Nerve conduction studies

    showed evidence of an axonal, mainly sensory,neuropathy. Echocardiography reveals symmetric,

    concentric ventricular hypertrophy.

    Approximately 65% of patients with FA haveabnormal ECG findings. Genetic testing for GAA

    expansion is positive in 95% of the homozygous

    form.

  • 8/3/2019 Ataxia .

    21/21

    Treatment

    There is currently no cure available for themajority of the cerebellar ataxias. Antioxident

    therapy including coenzyme Q10 and vitamin E

    are being evaluated. Supportive treatmentincludes physical therapy, speech therapy,

    psychological support and treatment of associated

    cardiac disease and diabetes. Genetic counseling

    should be offered.